IE00BYZK4776
IE00BYZK4776
iShares Healthcare Innovation UCITS ETF
Loading chart...
Holdings & Portfolio Structure
Holdings as of 08/30/2026Detailed breakdown of ETF components
All Holdings
| 1 |  | Moderna, Inc. | Healthcare | Biotechnology | 80,17 Mrd. € | 3.61% | - | -50.70 | 19.04% | 13.28 | 40.32 | -34.08 | 300.18 | 0.33% | FY Cur +8.09% (21) Q Cur -12.17% (14) FY Next +16.07% (19) Q Next -24.31% (13) | FY Cur -15.53% (21) Q Cur -149.18% (15) FY Next +43.00% (20) Q Next -37.19% (14) |
| 2 |  | Natera, Inc. | Healthcare | Diagnostics & Research | 51,55 Mrd. € | 1.84% | - | -2028.91 | 13.09% | 31.59 | 21.34 | -247.20 | 555.23 | 0.18% | FY Cur +26.17% (22) Q Cur +19.45% (20) FY Next +20.65% (22) Q Next +5.85% (18) | FY Cur +5.05% (16) Q Cur +58.50% (15) FY Next +86.32% (16) Q Next +60.98% (14) |
| 3 |  | Illumina, Inc. | Healthcare | Diagnostics & Research | 37,49 Mrd. € | 1.72% | 51.90 | 45.46 | 89.04% | 14.80 | 9.35 | 35.77 | 52.66 | 1.90% | FY Cur +6.48% (19) Q Cur +6.34% (17) FY Next +6.46% (19) Q Next +5.84% (16) | FY Cur +10.69% (21) Q Cur +1.31% (19) FY Next +14.20% (21) Q Next +13.15% (18) |
| 4 |  | IQVIA Holdings, Inc. | Healthcare | Diagnostics & Research | 38,18 Mrd. € | 1.70% | 32.28 | 18.01 | 257.98% | 6.93 | 2.52 | 18.67 | 19.90 | 5.03% | FY Cur +6.78% (20) Q Cur +6.47% (16) FY Next +6.05% (20) Q Next +3.85% (16) | FY Cur +8.70% (22) Q Cur +9.12% (19) FY Next +11.37% (22) Q Next +11.43% (18) |
| 5 |  | Genmab A/S | Healthcare | Biotechnology | 20,1 Mrd. € | 1.64% | 30.16 | 22.15 | 88.52% | 3.69 | 36.39 | 104.88 | 172.68 | 0.58% | FY Cur +25.99% (19) Q Cur +20.30% (11) FY Next +16.94% (21) Q Next +5.32% (11) | FY Cur -27.32% (10) Q Cur -45.92% (3) FY Next +35.70% (11) Q Next -13.48% (3) |
| 6 |  | Guardant Health, Inc. | Healthcare | Diagnostics & Research | 20,06 Mrd. € | 1.56% | - | -405.82 | - | - | 19.00 | -53.09 | 844.66 | 0.12% | FY Cur +38.24% (25) Q Cur +32.20% (21) FY Next +35.29% (25) Q Next +5.32% (20) | FY Cur +19.43% (21) Q Cur +19.79% (17) FY Next +71.86% (19) Q Next +11.31% (17) |
| 7 |  | Roivant Sciences Ltd. | Healthcare | Biotechnology | 22,85 Mrd. € | 1.56% | - | -20.63 | 2.18% | 6.05 | 3398.72 | -15.92 | - | -4.40% | FY Cur +530.75% (12) Q Cur +136.10% (11) FY Next +685.92% (12) Q Next +231.50% (11) | FY Cur -46.66% (3) Q Cur -63.34% (3) FY Next -8.69% (3) Q Next +8.42% (3) |
| 8 |  | Amgen Inc. | Healthcare | Drug Manufacturers - General | 200,18 Mrd. € | 1.53% | 25.77 | 16.94 | 490.28% | 19.19 | 5.89 | 15.27 | 25.94 | 3.85% | FY Cur +5.98% (31) Q Cur +5.15% (24) FY Next +3.62% (31) Q Next +2.19% (23) | FY Cur +5.47% (33) Q Cur +2.21% (27) FY Next +6.29% (33) Q Next +0.71% (27) |
| 9 |  | Merck & Company, Inc. | Healthcare | Drug Manufacturers - General | 320,6 Mrd. € | 1.51% | 115.56 | 15.62 | 128.41% | 8.57 | 5.40 | 13.79 | 23.68 | 4.22% | FY Cur +3.18% (24) Q Cur +0.29% (16) FY Next +4.39% (24) Q Next -3.04% (15) | FY Cur -70.07% (26) Q Cur -17.59% (18) FY Next +246.78% (25) Q Next -8.23% (18) |
| 10 |  | Celltrion | Healthcare | Biotechnology | 27,25 Mrd. € | 1.49% | - | 23.49 | 21.43% | - | 8.36 | 24.94 | - | -0.07% | FY Cur +34.20% (20) Q Cur +41.60% (15) FY Next +13.92% (22) Q Next +9.69% (15) | FY Cur +47.84% (22) Q Cur +15.15% (3) FY Next +16.52% (22) Q Next +4.18% (3) |
| 11 |  | Abbott Laboratories | Healthcare | Medical Devices | 154,83 Mrd. € | 1.48% | 31.82 | 16.42 | 63.21% | 3.37 | 3.72 | 16.97 | 24.06 | 4.16% | FY Cur +13.25% (27) Q Cur +14.30% (24) FY Next +8.62% (27) Q Next +4.21% (23) | FY Cur +7.12% (27) Q Cur +8.86% (23) FY Next +9.94% (27) Q Next +15.52% (22) |
| 12 |  | Medpace Holdings, Inc. | Healthcare | Diagnostics & Research | 15,25 Mrd. € | 1.46% | 35.94 | 31.69 | 33.22% | 39.37 | 6.14 | 26.94 | 33.47 | 2.99% | FY Cur +12.72% (13) Q Cur +8.27% (11) FY Next +6.33% (13) Q Next +0.89% (11) | FY Cur +15.94% (10) Q Cur +15.57% (8) FY Next +9.03% (10) Q Next +5.05% (8) |
| 13 |  | Revvity, Inc. | Healthcare | Diagnostics & Research | 15,35 Mrd. € | 1.46% | 73.77 | 26.18 | 46.23% | 2.38 | 5.91 | 22.03 | 28.44 | 3.52% | FY Cur -0.12% (16) Q Cur -0.60% (15) FY Next +5.40% (16) Q Next +9.33% (14) | FY Cur +5.77% (17) Q Cur +9.86% (16) FY Next +10.03% (17) Q Next +24.51% (15) |
| 14 |  | ARGENX SE | Healthcare | Biotechnology | 45,81 Mrd. € | 1.46% | 32.39 | 20.27 | 0.56% | 6.09 | 8.62 | 24.17 | 60.13 | 1.66% | FY Cur +48.20% (4) Q Cur +43.13% (2) FY Next +21.64% (4) Q Next +8.94% (2) | FY Cur +52.45% (2) Q Cur -538.82% (1) FY Next +20.45% (3) Q Next +140.47% (1) |
| 15 |  | Gilead Sciences, Inc. | Healthcare | Drug Manufacturers - General | 167,29 Mrd. € | 1.43% | - | 15.24 | 223.47% | 15.86 | 6.15 | 13.95 | 19.19 | 5.21% | FY Cur +4.36% (25) Q Cur +0.17% (20) FY Next +6.57% (24) Q Next +4.63% (17) | FY Cur -105.06% (27) Q Cur -11.85% (22) FY Next +2503.59% (26) Q Next -0.10% (20) |
| 16 |  | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 107,78 Mrd. € | 1.43% | 13.02 | 8.96 | 201.86% | 5.41 | 2.46 | 8.22 | 14.88 | 6.72% | FY Cur +3.49% (25) Q Cur +3.95% (20) FY Next -3.02% (25) Q Next -0.11% (19) | FY Cur +10.73% (27) Q Cur -5.15% (21) FY Next -3.08% (27) Q Next +3.55% (21) |
| 17 |  | Charles River Laboratories Inte | Healthcare | Diagnostics & Research | 12,86 Mrd. € | 1.43% | - | 23.62 | 105.05% | 5.07 | 3.60 | 20.16 | 30.73 | 3.25% | FY Cur -2.44% (12) Q Cur -4.43% (11) FY Next +2.50% (15) Q Next -0.53% (11) | FY Cur +10.54% (17) Q Cur +22.11% (13) FY Next +12.42% (17) Q Next +11.92% (13) |
| 18 |  | LONZA N | Healthcare | Diagnostics & Research | 42,95 Mrd. € | 1.42% | 37.92 | 25.94 | 51.12% | 4.92 | 5.82 | 18.00 | - | -3.92% | FY Cur +9.02% (23) Q Cur - (0) FY Next +11.47% (23) Q Next - (0) | FY Cur +23.28% (17) Q Cur - FY Next +19.03% (18) Q Next - |
| 19 |  | Agilent Technologies, Inc. | Healthcare | Diagnostics & Research | 42,91 Mrd. € | 1.41% | 33.64 | 25.24 | 56.34% | 6.53 | 6.52 | 23.94 | 45.34 | 2.21% | FY Cur +7.95% (20) Q Cur +6.87% (16) FY Next +6.42% (21) Q Next -3.19% (8) | FY Cur +10.94% (21) Q Cur +8.54% (18) FY Next +8.94% (22) Q Next -13.08% (11) |
| 20 |  | AbbVie Inc. | Healthcare | Drug Manufacturers - General | 436,04 Mrd. € | 1.38% | 78.10 | 17.01 | - | - | 7.59 | 17.74 | 28.96 | 3.45% | FY Cur +10.53% (24) Q Cur +9.79% (18) FY Next +8.80% (23) Q Next +5.55% (17) | FY Cur +39.85% (26) Q Cur +104.02% (18) FY Next +16.25% (25) Q Next +2.24% (17) |
| 21 |  | Danaher Corporation | Healthcare | Diagnostics & Research | 137,91 Mrd. € | 1.38% | 38.77 | 23.64 | 52.97% | 2.94 | 6.15 | 21.97 | 35.73 | 2.80% | FY Cur +7.26% (23) Q Cur +8.37% (19) FY Next +8.09% (23) Q Next +15.68% (17) | FY Cur +9.09% (25) Q Cur +1.39% (20) FY Next +9.29% (25) Q Next +34.80% (20) |
| 22 |  | DexCom, Inc. | Healthcare | Medical Devices | 28,33 Mrd. € | 1.38% | 33.38 | 26.90 | 53.35% | 12.11 | 6.39 | 22.31 | 31.08 | 3.22% | FY Cur +12.19% (27) Q Cur +9.89% (25) FY Next +10.89% (27) Q Next +5.43% (24) | FY Cur +27.47% (26) Q Cur +10.35% (23) FY Next +17.37% (26) Q Next +9.28% (22) |
| 23 |  | SAMSUNG BIOLOGICS | Healthcare | Biotechnology | 37,77 Mrd. € | 1.38% | - | 25.22 | 14.84% | - | 11.08 | 19.59 | 43.81 | 2.28% | FY Cur -3.86% (20) Q Cur -18.32% (13) FY Next +16.23% (20) Q Next +13.32% (11) | FY Cur +54.18% (19) Q Cur +21.41% (4) FY Next +17.75% (19) Q Next +20.07% (4) |
| 24 |  | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 562,31 Mrd. € | 1.36% | 29.71 | 21.26 | 57.71% | 7.41 | 6.43 | 18.54 | 37.31 | 2.68% | FY Cur +7.66% (12) Q Cur +5.84% (10) FY Next +7.04% (11) Q Next +4.27% (9) | FY Cur +2.70% (12) Q Cur -10.55% (11) FY Next +10.97% (11) Q Next +17.44% (10) |
| 25 |  | Biogen Inc. | Healthcare | Drug Manufacturers - General | 29,76 Mrd. € | 1.34% | 40.09 | 13.65 | 44.33% | 1.77 | 3.33 | 11.71 | 26.32 | 3.80% | FY Cur +5.66% (32) Q Cur +4.00% (26) FY Next +2.04% (32) Q Next -1.22% (25) | FY Cur -17.96% (33) Q Cur -57.93% (26) FY Next +31.94% (33) Q Next +61.72% (26) |
Results: 200
USWeight 3.61%
Market Cap €80.17B
P/E -
Fwd P/E -50.7
USWeight 1.84%
Market Cap €51.55B
P/E -
Fwd P/E -2028.9
USWeight 1.72%
Market Cap €37.49B
P/E 51.9
Fwd P/E 45.5
USWeight 1.7%
Market Cap €38.18B
P/E 32.3
Fwd P/E 18.0
DKWeight 1.64%
Market Cap €20.1B
P/E 30.2
Fwd P/E 22.1
USWeight 1.56%
Market Cap €20.06B
P/E -
Fwd P/E -405.8
GBWeight 1.56%
Market Cap €22.85B
P/E -
Fwd P/E -20.6
USWeight 1.53%
Market Cap €200.18B
P/E 25.8
Fwd P/E 16.9
USWeight 1.51%
Market Cap €320.6B
P/E 115.6
Fwd P/E 15.6
KRWeight 1.49%
Market Cap €27.25B
P/E -
Fwd P/E 23.5
USWeight 1.48%
Market Cap €154.83B
P/E 31.8
Fwd P/E 16.4
USWeight 1.46%
Market Cap €15.25B
P/E 35.9
Fwd P/E 31.7
USWeight 1.46%
Market Cap €15.35B
P/E 73.8
Fwd P/E 26.2
NLWeight 1.46%
Market Cap €45.81B
P/E 32.4
Fwd P/E 20.3
USWeight 1.43%
Market Cap €167.29B
P/E -
Fwd P/E 15.2
USWeight 1.43%
Market Cap €107.78B
P/E 13.0
Fwd P/E 9.0
USWeight 1.43%
Market Cap €12.86B
P/E -
Fwd P/E 23.6
CHWeight 1.42%
Market Cap €42.95B
P/E 37.9
Fwd P/E 25.9
USWeight 1.41%
Market Cap €42.91B
P/E 33.6
Fwd P/E 25.2
USWeight 1.38%
Market Cap €436.04B
P/E 78.1
Fwd P/E 17.0
USWeight 1.38%
Market Cap €137.91B
P/E 38.8
Fwd P/E 23.6
USWeight 1.38%
Market Cap €28.33B
P/E 33.4
Fwd P/E 26.9
KRWeight 1.38%
Market Cap €37.77B
P/E -
Fwd P/E 25.2
USWeight 1.36%
Market Cap €562.31B
P/E 29.7
Fwd P/E 21.3
USWeight 1.34%
Market Cap €29.76B
P/E 40.1
Fwd P/E 13.6
Results 1 - 25 of 200
Per page:
Page 1 / 8